speb/financial-data huggingface dataset:
MNOV balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -115285.00
MNOV income_statement (annual, 2022-12-31) — General And Administrative Expense: 5484857.00
MNOV balance_sheet (annual, 2022-12-31) — Goodwill: 9600240.00
MNOV balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 14400240.00
MNOV balance_sheet (annual, 2022-12-31) — Gross PPE: 1107564.00
MNOV cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
MNOV income_statement (annual, 2022-12-31) — Interest Income: 809673.00
MNOV income_statement (annual, 2022-12-31) — Interest Income Non Operating: 809673.00
MNOV balance_sheet (annual, 2022-12-31) — Invested Capital: 70242035.00
MNOV cash_flow (annual, 2022-12-31) — Investing Cash Flow: -40005010.00
MNOV cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 7920.00
MNOV balance_sheet (annual, 2022-12-31) — Leases: 13532.00
MNOV balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 464537.00
MNOV cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 7920.00
MNOV income_statement (annual, 2022-12-31) — Net Income: -14069083.00
MNOV income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -14069083.00
MNOV income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -14069083.00
MNOV income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -14069083.00
MNOV income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -14069083.00
MNOV cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -14069083.00
MNOV income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -14069083.00
MNOV income_statement (annual, 2022-12-31) — Net Interest Income: 809673.00
MNOV cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -40000000.00
MNOV income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 809673.00
MNOV balance_sheet (annual, 2022-12-31) — Net PPE: 674764.00
MNOV cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5010.00
MNOV balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 55841795.00
MNOV balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 201792.00
MNOV balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 201792.00
MNOV income_statement (annual, 2022-12-31) — Normalized EBITDA: -14610942.00
MNOV income_statement (annual, 2022-12-31) — Normalized Income: -14069083.00
MNOV cash_flow (annual, 2022-12-31) — Operating Cash Flow: -12911563.00
MNOV cash_flow (annual, 2022-12-31) — Operating Gains Losses: 122475.00
MNOV income_statement (annual, 2022-12-31) — Operating Income: -14628649.00
MNOV income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
MNOV balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 49046246.00
MNOV balance_sheet (annual, 2022-12-31) — Other Current Assets: 499403.00
MNOV balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 184100.00
MNOV balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -115285.00
MNOV income_statement (annual, 2022-12-31) — Other Gand A: 5484857.00
MNOV income_statement (annual, 2022-12-31) — Other Income Expense: -247285.00
MNOV balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4800000.00
MNOV cash_flow (annual, 2022-12-31) — Other Non Cash Items: 40716.00
MNOV balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 92792.00
MNOV balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 523619.00
MNOV income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -247285.00
MNOV balance_sheet (annual, 2022-12-31) — Other Properties: 629495.00
MNOV balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 39982213.00
MNOV balance_sheet (annual, 2022-12-31) — Payables: 424646.00
MNOV balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1925688.00
MNOV balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 920166.00
MNOV income_statement (annual, 2022-12-31) — Pretax Income: -14066261.00
MNOV cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
MNOV balance_sheet (annual, 2022-12-31) — Properties: 0.00
MNOV cash_flow (annual, 2022-12-31) — Purchase Of Investment: -59877526.00
MNOV cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5010.00
MNOV income_statement (annual, 2022-12-31) — Reconciled Depreciation: 17707.00
MNOV income_statement (annual, 2022-12-31) — Research And Development: 9143792.00
MNOV balance_sheet (annual, 2022-12-31) — Retained Earnings: -407130177.00
MNOV cash_flow (annual, 2022-12-31) — Sale Of Investment: 19877526.00
MNOV income_statement (annual, 2022-12-31) — Selling General And Administration: 5484857.00
MNOV balance_sheet (annual, 2022-12-31) — Share Issued: 49046246.00
MNOV cash_flow (annual, 2022-12-31) — Stock Based Compensation: 642522.00
MNOV balance_sheet (annual, 2022-12-31) — Stockholders Equity: 70242035.00
MNOV balance_sheet (annual, 2022-12-31) — Tangible Book Value: 55841795.00
MNOV income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
MNOV income_statement (annual, 2022-12-31) — Tax Provision: 2822.00
MNOV income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
MNOV balance_sheet (annual, 2022-12-31) — Total Assets: 74154905.00
MNOV balance_sheet (annual, 2022-12-31) — Total Capitalization: 70242035.00
MNOV balance_sheet (annual, 2022-12-31) — Total Debt: 157505.00
MNOV balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 70242035.00
MNOV income_statement (annual, 2022-12-31) — Total Expenses: 14628649.00
MNOV balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3912870.00
MNOV balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 15167796.00
MNOV balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 725411.00
MNOV income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -14628649.00
MNOV balance_sheet (annual, 2022-12-31) — Working Capital: 55799650.00
MNOV income_statement (annual, 2023-12-31) — +Operating Expense: 10900265.00
MNOV income_statement (annual, 2023-12-31) — +Total Revenue: 1000000.00
MNOV balance_sheet (annual, 2023-12-31) — Accounts Payable: 1003937.00
MNOV balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -443513.00
MNOV balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 478149161.00
MNOV income_statement (annual, 2023-12-31) — Basic Average Shares: 49046246.00
MNOV income_statement (annual, 2023-12-31) — Basic EPS: -0.17
MNOV cash_flow (annual, 2023-12-31) — Beginning Cash Position: 18505493.00
MNOV cash_flow (annual, 2023-12-31) — Capital Expenditure: -21299.00
MNOV balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 215926.00
MNOV balance_sheet (annual, 2023-12-31) — Capital Stock: 49046.00
MNOV balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 50999442.00
MNOV balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 50999442.00
MNOV cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 0.00
MNOV cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 39907716.00
MNOV cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -7431038.00
MNOV cash_flow (annual, 2023-12-31) — Change In Account Payable: 19238.00
MNOV cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -194880.00
MNOV cash_flow (annual, 2023-12-31) — Change In Payable: 19238.00
MNOV cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 19238.00
MNOV cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 287628.00
MNOV cash_flow (annual, 2023-12-31) — Change In Working Capital: 111986.00
MNOV cash_flow (annual, 2023-12-31) — Changes In Cash: 32476678.00
MNOV balance_sheet (annual, 2023-12-31) — Common Stock: 49046.00
MNOV balance_sheet (annual, 2023-12-31) — Common Stock Equity: 62378424.00
MNOV cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
MNOV balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1070473.00
MNOV balance_sheet (annual, 2023-12-31) — Current Assets: 51174380.00
MNOV balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 215926.00
MNOV balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 215926.00
MNOV balance_sheet (annual, 2023-12-31) — Current Liabilities: 3279101.00
MNOV cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 20295.00
MNOV cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 20295.00
MNOV income_statement (annual, 2023-12-31) — Diluted Average Shares: 49046246.00
MNOV income_statement (annual, 2023-12-31) — Diluted EPS: -0.17
MNOV income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -8571516.00
MNOV income_statement (annual, 2023-12-31) — EBIT: -9900265.00
MNOV income_statement (annual, 2023-12-31) — EBITDA: -9879970.00
MNOV cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 17271.00
MNOV cash_flow (annual, 2023-12-31) — End Cash Position: 50999442.00
MNOV cash_flow (annual, 2023-12-31) — Financing Cash Flow: 0.00
MNOV cash_flow (annual, 2023-12-31) — Free Cash Flow: -7452337.00
MNOV cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 448903.00
MNOV cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 472.00
MNOV balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -118090.00
MNOV income_statement (annual, 2023-12-31) — General And Administrative Expense: 5242370.00
MNOV balance_sheet (annual, 2023-12-31) — Goodwill: 9600240.00
MNOV balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 14400240.00
MNOV balance_sheet (annual, 2023-12-31) — Gross PPE: 1064719.00
MNOV cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 3667.00
MNOV income_statement (annual, 2023-12-31) — Interest Income: 1834665.00
MNOV income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1834665.00
MNOV balance_sheet (annual, 2023-12-31) — Invested Capital: 62378424.00
MNOV cash_flow (annual, 2023-12-31) — Investing Cash Flow: 39907716.00
MNOV cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
MNOV balance_sheet (annual, 2023-12-31) — Leases: 12579.00
MNOV balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 476734.00
MNOV cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
MNOV income_statement (annual, 2023-12-31) — Net Income: -8571516.00
MNOV income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -8571516.00
MNOV income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8571516.00
MNOV income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -8571516.00
MNOV income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -8571516.00
MNOV cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8571516.00
MNOV income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8571516.00
MNOV income_statement (annual, 2023-12-31) — Net Interest Income: 1834665.00
MNOV cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 39929015.00
MNOV income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1834665.00
MNOV balance_sheet (annual, 2023-12-31) — Net PPE: 621206.00
MNOV cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -21299.00
MNOV balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 47978184.00
MNOV balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 201792.00
MNOV balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 201792.00
MNOV income_statement (annual, 2023-12-31) — Normalized EBITDA: -9879970.00
MNOV income_statement (annual, 2023-12-31) — Normalized Income: -8571516.00
MNOV cash_flow (annual, 2023-12-31) — Operating Cash Flow: -7431038.00
MNOV cash_flow (annual, 2023-12-31) — Operating Gains Losses: 449375.00
MNOV income_statement (annual, 2023-12-31) — Operating Income: -9900265.00
MNOV income_statement (annual, 2023-12-31) — Operating Revenue: 1000000.00
MNOV balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 49046246.00
MNOV balance_sheet (annual, 2023-12-31) — Other Current Assets: 174938.00
MNOV balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 164375.00
MNOV balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -118090.00
MNOV income_statement (annual, 2023-12-31) — Other Gand A: 5242370.00
MNOV income_statement (annual, 2023-12-31) — Other Income Expense: -502869.00
MNOV balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 4800000.00
MNOV cash_flow (annual, 2023-12-31) — Other Non Cash Items: -151888.00
MNOV balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 74151.00
MNOV balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 410660.00
MNOV income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -502869.00
MNOV balance_sheet (annual, 2023-12-31) — Other Properties: 575406.00
MNOV balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
MNOV balance_sheet (annual, 2023-12-31) — Payables: 1003937.00
MNOV balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2074410.00
MNOV balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 824390.00
MNOV income_statement (annual, 2023-12-31) — Pretax Income: -8568469.00
MNOV balance_sheet (annual, 2023-12-31) — Properties: 0.00
MNOV cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
MNOV cash_flow (annual, 2023-12-31) — Purchase Of PPE: -21299.00
MNOV income_statement (annual, 2023-12-31) — Reconciled Depreciation: 20295.00
MNOV income_statement (annual, 2023-12-31) — Research And Development: 5657895.00
MNOV balance_sheet (annual, 2023-12-31) — Retained Earnings: -415701693.00
MNOV cash_flow (annual, 2023-12-31) — Sale Of Investment: 39929015.00
MNOV cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
MNOV income_statement (annual, 2023-12-31) — Selling General And Administration: 5242370.00
MNOV balance_sheet (annual, 2023-12-31) — Share Issued: 49046246.00
MNOV cash_flow (annual, 2023-12-31) — Stock Based Compensation: 710710.00
MNOV balance_sheet (annual, 2023-12-31) — Stockholders Equity: 62378424.00
MNOV balance_sheet (annual, 2023-12-31) — Tangible Book Value: 47978184.00
MNOV income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MNOV income_statement (annual, 2023-12-31) — Tax Provision: 3047.00
MNOV income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
MNOV balance_sheet (annual, 2023-12-31) — Total Assets: 66269977.00
MNOV balance_sheet (annual, 2023-12-31) — Total Capitalization: 62378424.00
MNOV balance_sheet (annual, 2023-12-31) — Total Debt: 215926.00
MNOV balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 62378424.00
MNOV income_statement (annual, 2023-12-31) — Total Expenses: 10900265.00
MNOV balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3891553.00
MNOV balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 15095597.00
MNOV balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 612452.00
MNOV income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -9900265.00
MNOV balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
MNOV balance_sheet (annual, 2023-12-31) — Working Capital: 47895279.00
MNOV income_statement (quarterly, 2024-09-30) — Basic Average Shares: 49046246.00
MNOV income_statement (quarterly, 2024-09-30) — Basic EPS: -0.06
MNOV cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -6.00
MNOV cash_flow (quarterly, 2024-09-30) — Change In Receivables: 0.00
MNOV cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 0.00
MNOV income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 49046246.00
MNOV income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.06
MNOV cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: -199.00
MNOV cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
MNOV balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 255150.00
MNOV cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
MNOV income_statement (annual, 2024-12-31) — +Operating Expense: 12675331.00
MNOV income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Accounts Payable: 1102494.00
MNOV balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -402734.00
MNOV balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -402734.00
MNOV balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 479340901.00
MNOV income_statement (annual, 2024-12-31) — Basic Average Shares: 49046246.00
MNOV income_statement (annual, 2024-12-31) — Basic EPS: -0.23
MNOV cash_flow (annual, 2024-12-31) — Beginning Cash Position: 50999442.00
MNOV cash_flow (annual, 2024-12-31) — Capital Expenditure: -895.00
MNOV balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 193769.00
MNOV balance_sheet (annual, 2024-12-31) — Capital Stock: 49046.00
MNOV balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 40359738.00
MNOV balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 40359738.00
MNOV cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
MNOV cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -697.00
MNOV cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -10642964.00
MNOV cash_flow (annual, 2024-12-31) — Change In Account Payable: -312347.00
MNOV cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -176204.00
MNOV cash_flow (annual, 2024-12-31) — Change In Payable: -312347.00
MNOV cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -312347.00
MNOV cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -491005.00
MNOV cash_flow (annual, 2024-12-31) — Change In Working Capital: -979556.00
MNOV cash_flow (annual, 2024-12-31) — Changes In Cash: -10643661.00
MNOV balance_sheet (annual, 2024-12-31) — Common Stock: 49046.00
MNOV balance_sheet (annual, 2024-12-31) — Common Stock Equity: 52503551.00
MNOV cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
MNOV income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 750079.00
MNOV balance_sheet (annual, 2024-12-31) — Current Assets: 41074279.00
MNOV balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 193769.00
MNOV balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 193769.00
MNOV balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
MNOV balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
MNOV balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Current Liabilities: 2959123.00
MNOV cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 21077.00
MNOV cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 21077.00
MNOV income_statement (annual, 2024-12-31) — Diluted Average Shares: 49046246.00
MNOV income_statement (annual, 2024-12-31) — Diluted EPS: -0.23
MNOV income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -11049549.00
MNOV income_statement (annual, 2024-12-31) — EBIT: -12675331.00
MNOV income_statement (annual, 2024-12-31) — EBITDA: -12654254.00
MNOV cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 3957.00
MNOV cash_flow (annual, 2024-12-31) — End Cash Position: 40359738.00
MNOV cash_flow (annual, 2024-12-31) — Financing Cash Flow: 0.00
MNOV cash_flow (annual, 2024-12-31) — Free Cash Flow: -10643859.00
MNOV cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -198.00
MNOV cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 1.00
MNOV balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -135154.00
MNOV income_statement (annual, 2024-12-31) — General And Administrative Expense: 5480600.00
MNOV balance_sheet (annual, 2024-12-31) — Goodwill: 9600240.00
MNOV balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 14400240.00
MNOV balance_sheet (annual, 2024-12-31) — Gross PPE: 785145.00
MNOV income_statement (annual, 2024-12-31) — Gross Profit: 0.00
MNOV cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 5042.00
MNOV income_statement (annual, 2024-12-31) — Interest Income: 1670804.00
MNOV income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1670804.00
MNOV balance_sheet (annual, 2024-12-31) — Invested Capital: 52503551.00
MNOV cash_flow (annual, 2024-12-31) — Investing Cash Flow: -697.00
MNOV cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Leases: 0.00
MNOV balance_sheet (quarterly, 2024-12-31) — Leases: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 428241.00
MNOV balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 428241.00
MNOV cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
MNOV income_statement (annual, 2024-12-31) — Net Income: -11049549.00
MNOV income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -11049549.00
MNOV income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -11049549.00
MNOV income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -11049549.00
MNOV income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -11049549.00
MNOV cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -11049549.00
MNOV income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -11049549.00
MNOV income_statement (annual, 2024-12-31) — Net Interest Income: 1670804.00
MNOV cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
MNOV cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
MNOV income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1670804.00
MNOV balance_sheet (annual, 2024-12-31) — Net PPE: 382411.00
MNOV cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -697.00
MNOV balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 38103311.00
MNOV balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 201792.00
MNOV balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 201792.00
MNOV income_statement (annual, 2024-12-31) — Normalized EBITDA: -12654254.00
MNOV income_statement (annual, 2024-12-31) — Normalized Income: -11049549.00
MNOV cash_flow (annual, 2024-12-31) — Operating Cash Flow: -10642964.00
MNOV cash_flow (annual, 2024-12-31) — Operating Gains Losses: -198.00
MNOV cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 1.00
MNOV income_statement (annual, 2024-12-31) — Operating Income: -12675331.00
MNOV income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 49046246.00
MNOV balance_sheet (annual, 2024-12-31) — Other Current Assets: 714541.00
MNOV balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 126832.00
MNOV balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 126832.00
MNOV balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -135154.00
MNOV income_statement (annual, 2024-12-31) — Other Gand A: 5480600.00
MNOV income_statement (annual, 2024-12-31) — Other Income Expense: -39485.00
MNOV balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 4800000.00
MNOV cash_flow (annual, 2024-12-31) — Other Non Cash Items: 173522.00
MNOV balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 18996.00
MNOV balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 18996.00
MNOV balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 211460.00
MNOV balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 211460.00
MNOV income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -39485.00
MNOV balance_sheet (annual, 2024-12-31) — Other Properties: 356904.00
MNOV balance_sheet (annual, 2024-12-31) — Payables: 1102494.00
MNOV balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1852573.00
MNOV balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 785949.00
MNOV balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 785949.00
MNOV income_statement (annual, 2024-12-31) — Pretax Income: -11044012.00
MNOV balance_sheet (annual, 2024-12-31) — Properties: 0.00
MNOV balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MNOV cash_flow (annual, 2024-12-31) — Purchase Of PPE: -895.00
MNOV income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
MNOV income_statement (annual, 2024-12-31) — Reconciled Depreciation: 21077.00
MNOV income_statement (annual, 2024-12-31) — Research And Development: 7194731.00
MNOV balance_sheet (annual, 2024-12-31) — Retained Earnings: -426751242.00
MNOV cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
MNOV cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
MNOV cash_flow (annual, 2024-12-31) — Sale Of PPE: 198.00
MNOV cash_flow (quarterly, 2024-12-31) — Sale Of PPE: -1.00
MNOV income_statement (annual, 2024-12-31) — Selling General And Administration: 5480600.00
MNOV balance_sheet (annual, 2024-12-31) — Share Issued: 49046246.00
MNOV cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1191740.00
MNOV balance_sheet (annual, 2024-12-31) — Stockholders Equity: 52503551.00
MNOV balance_sheet (annual, 2024-12-31) — Tangible Book Value: 38103311.00
MNOV income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MNOV income_statement (annual, 2024-12-31) — Tax Provision: 5537.00
MNOV income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MNOV balance_sheet (annual, 2024-12-31) — Total Assets: 55875926.00
MNOV balance_sheet (annual, 2024-12-31) — Total Capitalization: 52503551.00
MNOV balance_sheet (annual, 2024-12-31) — Total Debt: 193769.00
MNOV balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 52503551.00
MNOV income_statement (annual, 2024-12-31) — Total Expenses: 12675331.00
MNOV balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3372375.00
MNOV balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 14801647.00
MNOV balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 413252.00
MNOV income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -12675331.00
MNOV balance_sheet (annual, 2024-12-31) — Working Capital: 38115156.00
MNOV income_statement (quarterly, 2025-03-31) — +Operating Expense: 3202510.00
MNOV income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
MNOV balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 718891.00
MNOV balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 479626844.00
MNOV income_statement (quarterly, 2025-03-31) — Basic Average Shares: 49046246.00
MNOV income_statement (quarterly, 2025-03-31) — Basic EPS: -0.06
MNOV cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 40359738.00
MNOV balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 189860.00
MNOV balance_sheet (quarterly, 2025-03-31) — Capital Stock: 49046.00
MNOV balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 36571466.00
MNOV balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 36571466.00
MNOV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MNOV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3783661.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -812979.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -51210.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Payable: -812979.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -812979.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -391999.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
MNOV cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1256188.00
MNOV cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
MNOV cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3783661.00
MNOV balance_sheet (quarterly, 2025-03-31) — Common Stock: 49046.00
MNOV balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 49930476.00
MNOV income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
MNOV balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1224933.00
MNOV balance_sheet (quarterly, 2025-03-31) — Current Assets: 37679307.00
MNOV balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 189860.00
MNOV balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 189860.00
MNOV balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2133684.00
MNOV cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5177.00
MNOV cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5177.00
MNOV income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 49046246.00
MNOV income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.06
MNOV income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — EBIT: -3202510.00
MNOV income_statement (quarterly, 2025-03-31) — EBITDA: -3197333.00
MNOV cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -4611.00
MNOV cash_flow (quarterly, 2025-03-31) — End Cash Position: 36571466.00
MNOV cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3783661.00
MNOV balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -130052.00
MNOV income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1362708.00
MNOV balance_sheet (quarterly, 2025-03-31) — Goodwill: 9600240.00
MNOV balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 14400240.00
MNOV balance_sheet (quarterly, 2025-03-31) — Gross PPE: 332607.00
MNOV income_statement (quarterly, 2025-03-31) — Gross Profit: 0.00
MNOV income_statement (quarterly, 2025-03-31) — Interest Income: 336111.00
MNOV income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 336111.00
MNOV balance_sheet (quarterly, 2025-03-31) — Invested Capital: 49930476.00
MNOV cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
MNOV income_statement (quarterly, 2025-03-31) — Net Income: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2864120.00
MNOV cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2864120.00
MNOV income_statement (quarterly, 2025-03-31) — Net Interest Income: 336111.00
MNOV income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 336111.00
MNOV balance_sheet (quarterly, 2025-03-31) — Net PPE: 332607.00
MNOV cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
MNOV balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 35530236.00
MNOV balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 201792.00
MNOV balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 201792.00
MNOV income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3197333.00
MNOV income_statement (quarterly, 2025-03-31) — Normalized Income: -2864120.00
MNOV cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3783661.00
MNOV income_statement (quarterly, 2025-03-31) — Operating Income: -3202510.00
MNOV income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
MNOV balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 49046246.00
MNOV balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1107841.00
MNOV balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -130052.00
MNOV income_statement (quarterly, 2025-03-31) — Other Gand A: 1362708.00
MNOV income_statement (quarterly, 2025-03-31) — Other Income Expense: 2279.00
MNOV balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 4800000.00
MNOV cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 45527.00
MNOV balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 18996.00
MNOV balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 165198.00
MNOV income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2279.00
MNOV balance_sheet (quarterly, 2025-03-31) — Other Properties: 332607.00
MNOV balance_sheet (quarterly, 2025-03-31) — Payables: 718891.00
MNOV balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1943824.00
MNOV income_statement (quarterly, 2025-03-31) — Pretax Income: -2864120.00
MNOV cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
MNOV income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00
MNOV income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5177.00
MNOV income_statement (quarterly, 2025-03-31) — Research And Development: 1839802.00
MNOV balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -429615362.00
MNOV income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1362708.00
MNOV balance_sheet (quarterly, 2025-03-31) — Share Issued: 49046246.00
MNOV cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 285943.00
MNOV balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 49930476.00
MNOV balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 35530236.00
MNOV income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MNOV income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Assets: 52431150.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 49930476.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Debt: 189860.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 49930476.00
MNOV income_statement (quarterly, 2025-03-31) — Total Expenses: 3202510.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2500674.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 14751843.00
MNOV balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 366990.00
MNOV income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3202510.00
MNOV balance_sheet (quarterly, 2025-03-31) — Working Capital: 35545623.00
MNOV income_statement (quarterly, 2025-06-30) — +Operating Expense: 3625342.00
MNOV income_statement (quarterly, 2025-06-30) — +Total Revenue: 134599.00
MNOV balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 569445.00
MNOV balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 134599.00
MNOV balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 479831741.00
MNOV income_statement (quarterly, 2025-06-30) — Basic Average Shares: 49046246.00
MNOV income_statement (quarterly, 2025-06-30) — Basic EPS: -0.07
MNOV cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 36571466.00
MNOV balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 301880.00
MNOV balance_sheet (quarterly, 2025-06-30) — Capital Stock: 49046.00
MNOV balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 34259637.00
MNOV balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 34259637.00
MNOV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
MNOV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2306406.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 527129.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -53708.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Payable: 527129.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 527129.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 378791.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Receivables: -134599.00
MNOV cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 717613.00
MNOV cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -134599.00
MNOV cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2306406.00
MNOV balance_sheet (quarterly, 2025-06-30) — Common Stock: 49046.00
MNOV balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 46856869.00
MNOV income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 116349.00
MNOV balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1893889.00
MNOV balance_sheet (quarterly, 2025-06-30) — Current Assets: 35123834.00
MNOV balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 184842.00
MNOV balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 184842.00
MNOV balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2648176.00
MNOV cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5064.00
MNOV cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5064.00
MNOV income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 49046246.00
MNOV income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.07
MNOV income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — EBIT: -3607092.00
MNOV income_statement (quarterly, 2025-06-30) — EBITDA: -3602028.00
MNOV cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -5423.00
MNOV cash_flow (quarterly, 2025-06-30) — End Cash Position: 34259637.00
MNOV cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2306406.00
MNOV balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -127371.00
MNOV income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1436690.00
MNOV balance_sheet (quarterly, 2025-06-30) — Goodwill: 9600240.00
MNOV balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14400240.00
MNOV balance_sheet (quarterly, 2025-06-30) — Gross PPE: 280805.00
MNOV income_statement (quarterly, 2025-06-30) — Gross Profit: 18250.00
MNOV income_statement (quarterly, 2025-06-30) — Interest Income: 324955.00
MNOV income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 324955.00
MNOV balance_sheet (quarterly, 2025-06-30) — Invested Capital: 46856869.00
MNOV cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
MNOV balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 117038.00
MNOV balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 117038.00
MNOV income_statement (quarterly, 2025-06-30) — Net Income: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3281185.00
MNOV cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3281185.00
MNOV income_statement (quarterly, 2025-06-30) — Net Interest Income: 324955.00
MNOV income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 324955.00
MNOV balance_sheet (quarterly, 2025-06-30) — Net PPE: 280805.00
MNOV cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
MNOV balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 32456629.00
MNOV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 201792.00
MNOV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 201792.00
MNOV income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3602028.00
MNOV income_statement (quarterly, 2025-06-30) — Normalized Income: -3281185.00
MNOV cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2306406.00
MNOV income_statement (quarterly, 2025-06-30) — Operating Income: -3607092.00
MNOV income_statement (quarterly, 2025-06-30) — Operating Revenue: 134599.00
MNOV balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 49046246.00
MNOV balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 729598.00
MNOV balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -127371.00
MNOV income_statement (quarterly, 2025-06-30) — Other Gand A: 1436690.00
MNOV income_statement (quarterly, 2025-06-30) — Other Income Expense: 952.00
MNOV balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 4800000.00
MNOV cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 47205.00
MNOV balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 18996.00
MNOV income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 952.00
MNOV balance_sheet (quarterly, 2025-06-30) — Other Properties: 280805.00
MNOV balance_sheet (quarterly, 2025-06-30) — Payables: 569445.00
MNOV balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2463334.00
MNOV income_statement (quarterly, 2025-06-30) — Pretax Income: -3281185.00
MNOV cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
MNOV balance_sheet (quarterly, 2025-06-30) — Receivables: 134599.00
MNOV income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 116349.00
MNOV income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5064.00
MNOV income_statement (quarterly, 2025-06-30) — Research And Development: 2188652.00
MNOV balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -432896547.00
MNOV income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1436690.00
MNOV balance_sheet (quarterly, 2025-06-30) — Share Issued: 49046246.00
MNOV cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 204897.00
MNOV balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 46856869.00
MNOV balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 32456629.00
MNOV income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MNOV income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Assets: 49823875.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 46856869.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Debt: 301880.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 46856869.00
MNOV income_statement (quarterly, 2025-06-30) — Total Expenses: 3741691.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2967006.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 14700041.00
MNOV balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 318830.00
MNOV income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3607092.00
MNOV balance_sheet (quarterly, 2025-06-30) — Working Capital: 32475658.00
MNOV income_statement (quarterly, 2025-09-30) — +Operating Expense: 3389045.00
MNOV income_statement (quarterly, 2025-09-30) — +Total Revenue: 123319.00
MNOV balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 745958.00
MNOV balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 479989433.00
MNOV income_statement (quarterly, 2025-09-30) — Basic Average Shares: 49046246.00
MNOV income_statement (quarterly, 2025-09-30) — Basic EPS: -0.06
MNOV cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 34259637.00
MNOV balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 180751.00
MNOV balance_sheet (quarterly, 2025-09-30) — Capital Stock: 49046.00
MNOV balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 32562612.00
MNOV balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 32562612.00
MNOV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2899.00
MNOV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1703197.00
MNOV cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 163331.00
MNOV cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -46674.00
MNOV cash_flow (quarterly, 2025-09-30) — Change In Payable: 163331.00
MNOV cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 163331.00
MNOV cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 369325.00
MNOV cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1142480.00
MNOV cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1706096.00
MNOV balance_sheet (quarterly, 2025-09-30) — Common Stock: 49046.00
MNOV balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 43964756.00
MNOV income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 115272.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1888833.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Assets: 32922521.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 180751.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 180751.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 521899.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 521899.00
MNOV balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3337441.00
MNOV cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5303.00
MNOV cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5303.00
MNOV income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 49046246.00
MNOV income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.06
MNOV income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3050373.00
MNOV income_statement (quarterly, 2025-09-30) — EBIT: -3380998.00
MNOV income_statement (quarterly, 2025-09-30) — EBITDA: -3375695.00
MNOV cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 9071.00
MNOV cash_flow (quarterly, 2025-09-30) — End Cash Position: 32562612.00
MNOV cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1706096.00
MNOV balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -126803.00
MNOV income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1806070.00
MNOV balance_sheet (quarterly, 2025-09-30) — Goodwill: 9600240.00
MNOV balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14400240.00
MNOV balance_sheet (quarterly, 2025-09-30) — Gross PPE: 236631.00
MNOV income_statement (quarterly, 2025-09-30) — Gross Profit: 8047.00
MNOV income_statement (quarterly, 2025-09-30) — Interest Income: 340850.00
MNOV income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 340850.00
MNOV balance_sheet (quarterly, 2025-09-30) — Invested Capital: 43964756.00
MNOV cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2899.00
MNOV income_statement (quarterly, 2025-09-30) — Net Income: -3050373.00
MNOV income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3050373.00
MNOV income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3050373.00